Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rocky Mountain Cancer Center
Denver, Colorado, United States
- Florida Cancer Specialists-South
Fort Myers, Florida, United States
- Florida Hospital Cancer Insitute
Orlando, Florida, United States
- Florida Cancer Specialists-North
St. Petersburg, Florida, United States
- Baptist Hospital East
Louisville, Kentucky, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Research Medical Center
Kansas City, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Hematology-Oncology Associates of Northern Nj
Morristown, New Jersey, United States
- Oncology Hematology Care, Inc.
Cincinnati, Ohio, United States
- South Carolina Oncology Associates
Columbia, South Carolina, United States
- Tennessee Oncology - Chattanooga
Chattanooga, Tennessee, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- the Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
- Peninsula Cancer Institute
Newport News, Virginia, United States
- Virginia Cancer Institute
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 19 Apr 2017
- Completion
- 19 Apr 2017
- Last update posted
- 8 Jun 2018
- Registered enrollment
- 155
- Registry id
- NCT01829113
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.